Feline visceral hemangiosarcoma

William T Culp, K. J. Drobatz, M. M. Glassman, J. L. Baez, L. R. Aronson

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background: Feline visceral hemangiosarcoma (HSA) is an uncommon tumor, and the clinical progression and outcome are rarely reported. Hypothesis: The prognosis of feline visceral HSA is poor because of severe clinical signs, anemia, and a high rate of metastasis. Animals: The medical records of 26 client-owned cats with visceral HSA were reviewed. Methods: Multi-institutional retrospective study. Results: The most common historical findings and clinical signs included lethargy, anorexia, respiratory difficulty, collapse, and vocalizing. Eighty-two percent of cats were anemic, and aspartate transaminase was increased in 53% of the study population. Metastatic lung disease was noted in 33% of affected cats. In 75% of the cats, abdominal ultrasonography identified a specific location of HSA. However, ultrasound identification of all multifocal lesions was successful only in 3/9 cats (33%). Tumor location was identified in the following organs: liver (35%), small intestine (31%), large intestine (31%), abdominal lymph node (31%), mesentery (27%), spleen (23%), lung (19%), omentum (12%), brain (8%), pancreas (8%), and diaphragm (8%). Multifocal HSA was noted in 77% of cats. Three cats received adjuvant chemotherapy (doxorubicin). Seventy-one percent of euthanized cats were euthanized within 1 day of diagnosis. The median survival time of the remaining cats (n = 6) was 77 days (range, 23-296 days). Conclusion and Clinical Importance: Feline visceral HSA is most often multifocal at the time of diagnosis. The prognosis appears poor, and the number of cats receiving chemotherapy is low.

Original languageEnglish (US)
Pages (from-to)148-152
Number of pages5
JournalJournal of Veterinary Internal Medicine
Volume22
Issue number1
DOIs
StatePublished - Jan 2008
Externally publishedYes

Fingerprint

hemangiosarcoma
Hemangiosarcoma
Felidae
Cats
cats
prognosis
drug therapy
Lethargy
Omentum
Mesentery
Large Intestine
Anorexia
Adjuvant Chemotherapy
omentum
Aspartate Aminotransferases
Diaphragm
mesentery
Doxorubicin
neoplasms
doxorubicin

Keywords

  • Cat
  • Malignant
  • Neoplasia

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Culp, W. T., Drobatz, K. J., Glassman, M. M., Baez, J. L., & Aronson, L. R. (2008). Feline visceral hemangiosarcoma. Journal of Veterinary Internal Medicine, 22(1), 148-152. https://doi.org/10.1111/j.1939-1676.2008.0022.x

Feline visceral hemangiosarcoma. / Culp, William T; Drobatz, K. J.; Glassman, M. M.; Baez, J. L.; Aronson, L. R.

In: Journal of Veterinary Internal Medicine, Vol. 22, No. 1, 01.2008, p. 148-152.

Research output: Contribution to journalArticle

Culp, WT, Drobatz, KJ, Glassman, MM, Baez, JL & Aronson, LR 2008, 'Feline visceral hemangiosarcoma', Journal of Veterinary Internal Medicine, vol. 22, no. 1, pp. 148-152. https://doi.org/10.1111/j.1939-1676.2008.0022.x
Culp, William T ; Drobatz, K. J. ; Glassman, M. M. ; Baez, J. L. ; Aronson, L. R. / Feline visceral hemangiosarcoma. In: Journal of Veterinary Internal Medicine. 2008 ; Vol. 22, No. 1. pp. 148-152.
@article{05223b66870547fbb4223b85d2746bf3,
title = "Feline visceral hemangiosarcoma",
abstract = "Background: Feline visceral hemangiosarcoma (HSA) is an uncommon tumor, and the clinical progression and outcome are rarely reported. Hypothesis: The prognosis of feline visceral HSA is poor because of severe clinical signs, anemia, and a high rate of metastasis. Animals: The medical records of 26 client-owned cats with visceral HSA were reviewed. Methods: Multi-institutional retrospective study. Results: The most common historical findings and clinical signs included lethargy, anorexia, respiratory difficulty, collapse, and vocalizing. Eighty-two percent of cats were anemic, and aspartate transaminase was increased in 53{\%} of the study population. Metastatic lung disease was noted in 33{\%} of affected cats. In 75{\%} of the cats, abdominal ultrasonography identified a specific location of HSA. However, ultrasound identification of all multifocal lesions was successful only in 3/9 cats (33{\%}). Tumor location was identified in the following organs: liver (35{\%}), small intestine (31{\%}), large intestine (31{\%}), abdominal lymph node (31{\%}), mesentery (27{\%}), spleen (23{\%}), lung (19{\%}), omentum (12{\%}), brain (8{\%}), pancreas (8{\%}), and diaphragm (8{\%}). Multifocal HSA was noted in 77{\%} of cats. Three cats received adjuvant chemotherapy (doxorubicin). Seventy-one percent of euthanized cats were euthanized within 1 day of diagnosis. The median survival time of the remaining cats (n = 6) was 77 days (range, 23-296 days). Conclusion and Clinical Importance: Feline visceral HSA is most often multifocal at the time of diagnosis. The prognosis appears poor, and the number of cats receiving chemotherapy is low.",
keywords = "Cat, Malignant, Neoplasia",
author = "Culp, {William T} and Drobatz, {K. J.} and Glassman, {M. M.} and Baez, {J. L.} and Aronson, {L. R.}",
year = "2008",
month = "1",
doi = "10.1111/j.1939-1676.2008.0022.x",
language = "English (US)",
volume = "22",
pages = "148--152",
journal = "Journal of Veterinary Internal Medicine",
issn = "0891-6640",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Feline visceral hemangiosarcoma

AU - Culp, William T

AU - Drobatz, K. J.

AU - Glassman, M. M.

AU - Baez, J. L.

AU - Aronson, L. R.

PY - 2008/1

Y1 - 2008/1

N2 - Background: Feline visceral hemangiosarcoma (HSA) is an uncommon tumor, and the clinical progression and outcome are rarely reported. Hypothesis: The prognosis of feline visceral HSA is poor because of severe clinical signs, anemia, and a high rate of metastasis. Animals: The medical records of 26 client-owned cats with visceral HSA were reviewed. Methods: Multi-institutional retrospective study. Results: The most common historical findings and clinical signs included lethargy, anorexia, respiratory difficulty, collapse, and vocalizing. Eighty-two percent of cats were anemic, and aspartate transaminase was increased in 53% of the study population. Metastatic lung disease was noted in 33% of affected cats. In 75% of the cats, abdominal ultrasonography identified a specific location of HSA. However, ultrasound identification of all multifocal lesions was successful only in 3/9 cats (33%). Tumor location was identified in the following organs: liver (35%), small intestine (31%), large intestine (31%), abdominal lymph node (31%), mesentery (27%), spleen (23%), lung (19%), omentum (12%), brain (8%), pancreas (8%), and diaphragm (8%). Multifocal HSA was noted in 77% of cats. Three cats received adjuvant chemotherapy (doxorubicin). Seventy-one percent of euthanized cats were euthanized within 1 day of diagnosis. The median survival time of the remaining cats (n = 6) was 77 days (range, 23-296 days). Conclusion and Clinical Importance: Feline visceral HSA is most often multifocal at the time of diagnosis. The prognosis appears poor, and the number of cats receiving chemotherapy is low.

AB - Background: Feline visceral hemangiosarcoma (HSA) is an uncommon tumor, and the clinical progression and outcome are rarely reported. Hypothesis: The prognosis of feline visceral HSA is poor because of severe clinical signs, anemia, and a high rate of metastasis. Animals: The medical records of 26 client-owned cats with visceral HSA were reviewed. Methods: Multi-institutional retrospective study. Results: The most common historical findings and clinical signs included lethargy, anorexia, respiratory difficulty, collapse, and vocalizing. Eighty-two percent of cats were anemic, and aspartate transaminase was increased in 53% of the study population. Metastatic lung disease was noted in 33% of affected cats. In 75% of the cats, abdominal ultrasonography identified a specific location of HSA. However, ultrasound identification of all multifocal lesions was successful only in 3/9 cats (33%). Tumor location was identified in the following organs: liver (35%), small intestine (31%), large intestine (31%), abdominal lymph node (31%), mesentery (27%), spleen (23%), lung (19%), omentum (12%), brain (8%), pancreas (8%), and diaphragm (8%). Multifocal HSA was noted in 77% of cats. Three cats received adjuvant chemotherapy (doxorubicin). Seventy-one percent of euthanized cats were euthanized within 1 day of diagnosis. The median survival time of the remaining cats (n = 6) was 77 days (range, 23-296 days). Conclusion and Clinical Importance: Feline visceral HSA is most often multifocal at the time of diagnosis. The prognosis appears poor, and the number of cats receiving chemotherapy is low.

KW - Cat

KW - Malignant

KW - Neoplasia

UR - http://www.scopus.com/inward/record.url?scp=40549129398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40549129398&partnerID=8YFLogxK

U2 - 10.1111/j.1939-1676.2008.0022.x

DO - 10.1111/j.1939-1676.2008.0022.x

M3 - Article

VL - 22

SP - 148

EP - 152

JO - Journal of Veterinary Internal Medicine

JF - Journal of Veterinary Internal Medicine

SN - 0891-6640

IS - 1

ER -